Available Technologies
# of Displayed Technologies: 2 / 2
Applied Category Filter (Click To Remove): Cell Lines
LYMPHOBLASTIC LEUKEMIA/HIGH-GRADE LYMPHOMA miR155 TRANSGENIC MICE
TS-062319 — The Need
The urgent need to address lymphoproliferative disorders, including B cell malignancies such as acute lymphoblastic leukemia (ALL) and high-grade lymphomas, drives the demand for innovative and effective therapeutic approaches. These aggressive diseases, characterized by the uncontrolled p…
- College: College of Medicine (COM)
- Inventors: Croce, Carlo
- Licensing Officer: Willson, Christopher
Nras Mouse Melanoma Cell Lines
TS-049491 — Dr. Christin Burd's lab at The Ohio State University has developed a set of Nras-mutant mouse melanoma cell lines that can be used for preclinical tumor immunology and cancer biology studies.
Studies show that 15-30% of melanomas are Nras driven and 60% of melanomas are Braf driven. Dr. Christin Burd's lab at The Ohio State University has developed a set of Nras-mutant mouse melanoma cell lines that complement a set of Braf cell lines developed by Marcus Bosenberg at Yale Universit…
- College: College of Medicine (COM)
- Inventors: Burd, Christin; Murphy, Brandon
- Licensing Officer: Taysavang, Panya
